Everything ages over time. And human stem cells are no exception. Understanding this aging process may help explain why the elderly are more susceptible to infections and certain cancers.

Research into more effective treatments for chronic myeloid leukemia is opening up all sorts of possibilities. Drugs are being combined, new drugs are being developed and there is even work involving a possible vaccine.

The outlook for people with chronic myeloid leukemia has improved by leaps and bounds in recent years. A number of medications are now keeping the disease under wraps.

Finding new uses for existing drugs has taken on new emphasis of late. With advanced technology making it easier to test for "new" benefits in existing drugs, medical researchers may have hit a home run with an old antibiotic.

So you have to take a pill every day. It's saving your life, but doing anything every single day for the rest of your life is daunting. Recent research looked at which medications leukemia patients take more faithfully.

Genes are continuing to be the superheroes of treatment breakthroughs. A new study has discovered a gene linked to leukemia coming back in younger patients.

Teaming up with a partner makes any difficult task easier. When therapies team up even the difficult task of dealing with an incurable disease is made easier.

Just because something works in mice, doesn't mean it will work in humans. That being said, a new mouse study holds out hope for a new therapy for lymphoma. Researchers have identified two molecules that are better killers of lymphoma than existing therapies. These findings, if they hold true for humans, could lead to new cancer therapies. Ask your doctor about the very latest science relating to lymphoma therapies. First author Hye-Ra Lee, Ph.D., a research fellow in the Department of Molecular Microbiology & Immunology at the Keck School of Medicine of the University of So...

The Fourth American Association of Cancer Research ( AACR ) Conference on The Science of Cancer Health Disparities is demonstrating that different races live with and survive cancers at very different rates. Acute leukemia is no exception.

Acute leukemias occur rapidly and are often extremely difficult to treat. Researchers have found that an existing cardiovascular medication may offer new treatment options.